BLOG

Saturday, January 11, 2020

Lupin gets 2 observations from USFDA after Nagpur facility inspection

The USFDA issues observations by means of Form 483 notifying a company's management of objectionable conditions at the facility inspected

from Companies https://ift.tt/37WnNrW
via IFTTT
at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Omicron has cast a shadow of uncertainty on growth outlook: IndiGo CEO

However, the airline is stronger now when compared to situation in 2020 during the first wave of the pandemic, says Ronojoy Dutta from Com...